Jens Ingwersen

1.3k total citations
22 papers, 817 citations indexed

About

Jens Ingwersen is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, Jens Ingwersen has authored 22 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 7 papers in Neurology. Recurrent topics in Jens Ingwersen's work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Jens Ingwersen is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Jens Ingwersen collaborates with scholars based in Germany, Australia and Austria. Jens Ingwersen's co-authors include Orhan Aktaş, Hans‐Peter Hartung, Michael Bachmann, Bernd C. Kieseier, Marc Schmitz, Knut Schäkel, Claudia Günther, Ernst Peter Rieber, Michael J. Meurer and Reiner Schneider and has published in prestigious journals such as Scientific Reports, Journal of Allergy and Clinical Immunology and Journal of Neurochemistry.

In The Last Decade

Jens Ingwersen

22 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens Ingwersen Germany 14 294 261 236 198 103 22 817
Magdalena Paterka Germany 14 442 1.5× 255 1.0× 202 0.9× 239 1.2× 52 0.5× 19 844
Ewoud Ewing Sweden 14 331 1.1× 124 0.5× 392 1.7× 249 1.3× 32 0.3× 27 933
Lisette Montagne Netherlands 12 300 1.0× 235 0.9× 248 1.1× 343 1.7× 93 0.9× 12 877
Stéphanie Zandee Canada 18 404 1.4× 188 0.7× 438 1.9× 471 2.4× 88 0.9× 33 1.2k
Yoshinobu Okuda Japan 16 428 1.5× 236 0.9× 234 1.0× 190 1.0× 63 0.6× 22 874
Sarah C. Starossom United States 11 374 1.3× 81 0.3× 274 1.2× 227 1.1× 44 0.4× 15 754
Giuseppe Locatelli Germany 15 623 2.1× 193 0.7× 471 2.0× 739 3.7× 93 0.9× 40 1.5k
Amber L. Rowse United States 12 265 0.9× 88 0.3× 287 1.2× 288 1.5× 228 2.2× 13 847
Áine C. Murphy Ireland 8 318 1.1× 146 0.6× 228 1.0× 225 1.1× 27 0.3× 10 735
Hyesook Yoon United States 19 69 0.2× 147 0.6× 272 1.2× 143 0.7× 72 0.7× 30 908

Countries citing papers authored by Jens Ingwersen

Since Specialization
Citations

This map shows the geographic impact of Jens Ingwersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Ingwersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Ingwersen more than expected).

Fields of papers citing papers by Jens Ingwersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Ingwersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Ingwersen. The network helps show where Jens Ingwersen may publish in the future.

Co-authorship network of co-authors of Jens Ingwersen

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Ingwersen. A scholar is included among the top collaborators of Jens Ingwersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Ingwersen. Jens Ingwersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ingwersen, Jens, Lars Masanneck, Marc Pawlitzki, et al.. (2023). Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials. Scientific Reports. 13(1). 15003–15003. 13 indexed citations
2.
Pfeuffer, Steffen, Leoni Rolfes, Jens Ingwersen, et al.. (2023). Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab. Neurology Neuroimmunology & Neuroinflammation. 10(3). 4 indexed citations
3.
Ingwersen, Jens, Jonas Graf, Michael Dietrich, et al.. (2021). CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy. Neurology Neuroimmunology & Neuroinflammation. 9(1). 8 indexed citations
4.
Cruz-Herranz, Andrés, Michael Dietrich, Alexander Hilla, et al.. (2019). Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 16(1). 203–203. 32 indexed citations
5.
Prozorovski, Tim, Jens Ingwersen, Peter Göttle, et al.. (2019). Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cells. Neuroscience Letters. 704. 116–125. 24 indexed citations
6.
Graf, Jonas, Jens Ingwersen, Klaudia Lepka, et al.. (2019). Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases. Acta Neurologica Scandinavica. 140(4). 290–295. 4 indexed citations
7.
Ingwersen, Jens, Lorenzo De Santi, Britta Wingerath, et al.. (2018). Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitis. Journal of Neurochemistry. 146(1). 86–98. 28 indexed citations
8.
Graf, Jonas, Jens Ingwersen, Marius Ringelstein, et al.. (2018). Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy. Annals of Clinical and Translational Neurology. 5(8). 952–961. 8 indexed citations
9.
Lepka, Klaudia, Eckhard Bill, Reiner Schneider, et al.. (2017). Iron‐sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia. Glia. 65(9). 1521–1534. 35 indexed citations
10.
Ingwersen, Jens, Britta Wingerath, Jonas Graf, et al.. (2016). Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. Journal of Neuroinflammation. 13(1). 48–48. 73 indexed citations
11.
Schneider, Reiner, Barbara Koop, Friederike Schröter, et al.. (2016). Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitis. Molecular Neurodegeneration. 11(1). 53–53. 17 indexed citations
12.
Ingwersen, Jens, Orhan Aktaş, & Hans‐Peter Hartung. (2015). Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis. Neurotherapeutics. 13(1). 47–57. 32 indexed citations
13.
Schneider, Reiner, Michael Gliem, Jens Ingwersen, et al.. (2015). IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity. Acta Neuropathologica Communications. 3(1). 20–20. 92 indexed citations
14.
Ingwersen, Jens, Til Menge, Britta Wingerath, et al.. (2014). Natalizumab restores aberrant miRNAexpression profile in multiple sclerosis and reveals a critical role for miR‐20b. Annals of Clinical and Translational Neurology. 2(1). 43–55. 68 indexed citations
15.
Schneider, Reiner, Jens Ingwersen, Judith Alferink, et al.. (2014). IFNbeta secreted by microglia mediates clearance of myelin debris associated with CNS autoimmunity. Journal of Neuroimmunology. 275(1-2). 169–169. 5 indexed citations
16.
Ringelstein, Marius, Jens Harmel, Felix Distelmaier, et al.. (2013). Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum. Multiple Sclerosis Journal. 19(11). 1544–1547. 42 indexed citations
17.
Günther, Claudia, Jens Ingwersen, Marc Schmitz, et al.. (2011). Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong T 17/T 1 T-cell responses. Journal of Allergy and Clinical Immunology. 127(3). 787–794.e9. 173 indexed citations
18.
Ingwersen, Jens, et al.. (2011). Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy. Clinical Immunology. 142(1). 15–24. 87 indexed citations
19.
Aktaş, Orhan, Jens Ingwersen, B. C. Kieseier, et al.. (2010). Orales Fingolimod bei Multipler Sklerose. Der Nervenarzt. 82(2). 215–225. 4 indexed citations
20.
Huehnchen, Petra, Timour Prozorovski, Anne Lesemann, et al.. (2010). Modulation of adult hippocampal neurogenesis during myelin‐directed autoimmune neuroinflammation. Glia. 59(1). 132–142. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Paterka Breakdown of academic impact, for papers by Ewoud Ewing Breakdown of academic impact, for papers by Lisette Montagne Breakdown of academic impact, for papers by Stéphanie Zandee Breakdown of academic impact, for papers by Yoshinobu Okuda Breakdown of academic impact, for papers by Sarah C. Starossom Breakdown of academic impact, for papers by Giuseppe Locatelli Breakdown of academic impact, for papers by Amber L. Rowse Breakdown of academic impact, for papers by Áine C. Murphy Breakdown of academic impact, for papers by Hyesook Yoon
Rankless by CCL
2026